The Journal of Immunology, Vol 141, Issue 5 1602-1609, Copyright © 1988 by American Association of Immunologists

ARTICLES

Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies

CE Hack, J Paardekooper, RJ Smeenk, J Abbink, AJ Eerenberg and JH Nuijens
Central Laboratory, The Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Hydrolysis of the internal thioester bond in native C3 is thought to be a key event in initiating the alternative pathway of C activation, because the resulting C3(H2O) acquires "C3b-like" properties. Therefore, disruption of the internal thioester bond is probably accompanied by conformational changes in the C3 molecule. In this study, we demonstrate that such conformational changes indeed occur; 7 of the 19 mAb raised against C3 or C3 activation products recognized epitopes exposed on C3(H2O) but not on native C3. One of these epitopes is located on the C3a part, three on the C3c part, and another three on the C3d,g part. Because the 7 mAb bound equally well to C3 incubated either with MgCl2 or with methylamine (which primarily disrupts the thioester), the conformational changes detected by the mAb apparently occur after disruption of the thioester. Furthermore, the epitopes were also present on the corresponding C3 activation products. Immunoblotting experiments revealed that the epitopes for the three anti-C3d,g mAb were located on the C3d part, C-terminal to the thioester. The epitopes for 2 of the 3 anti-C3c mAb were located on the C-terminal alpha-chain fragment of C3c. Thus, this study provides immunochemical evidence for the biologic resemblance between C3(H2O) and C3 activation products. Implications of these findings for the activation process of C3 are discussed.

This article has been cited by other articles:

				M. Hammel, G. Sfyroera, S. Pyrpassopoulos, D. Ricklin, K. X. Ramyar, M. Pop, Z. Jin, J. D. Lambris, and B. V. Geisbrecht Characterization of Ehp, a Secreted Complement Inhibitory Protein from Staphylococcus aureus J. Biol. Chem., October 12, 2007; 282(41): 30051 - 30061. [Abstract] [Full Text] [PDF]

				E. Biro, R. Nieuwland, P. P Tak, L. M Pronk, M. C L Schaap, A. Sturk, and C E. Hack Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals Ann Rheum Dis, August 1, 2007; 66(8): 1085 - 1092. [Abstract] [Full Text] [PDF]

				N. Nishida, T. Walz, and T. A. Springer Structural transitions of complement component C3 and its activation products PNAS, December 26, 2006; 103(52): 19737 - 19742. [Abstract] [Full Text] [PDF]

				M. S. Winters, D. S. Spellman, and J. D. Lambris Solvent Accessibility of Native and Hydrolyzed Human Complement Protein 3 Analyzed by Hydrogen/Deuterium Exchange and Mass Spectrometry J. Immunol., March 15, 2005; 174(6): 3469 - 3474. [Abstract] [Full Text] [PDF]

				E. J Fransen, Y. M Ganushchak, V. Vijay, D. S de Jong, W. A Buurman, and J. G Maessen Evaluation of a new condensed extra-corporeal circuit for cardiac surgery: a prospective randomized clinical pilot study Perfusion, March 1, 2005; 20(2): 91 - 99. [Abstract] [PDF]

				E H A Spaenij-Dekking, E M C Kooy-Winkelaar, W F Nieuwenhuizen, J W Drijfhout, and F Koning A novel and sensitive method for the detection of T cell stimulatory epitopes of {alpha}/{beta}- and {gamma}-gliadin Gut, September 1, 2004; 53(9): 1267 - 1273. [Abstract] [Full Text] [PDF]

				M. C. M. Strik, A. Wolbink, D. Wouters, B. A. Bladergroen, A. R. Verlaan, I. S. van Houdt, S. Hijlkema, C. E. Hack, and J. A. Kummer Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with {beta}-tryptase monomers Blood, April 1, 2004; 103(7): 2710 - 2717. [Abstract] [Full Text] [PDF]

				E. H. A. Spaeny-Dekking, W. L. Hanna, A. M. Wolbink, P. C. Wever, A. J. Kummer, A. J. G. Swaak, J. M. Middeldorp, H. G. Huisman, C. J. Froelich, and C. E. Hack Extracellular Granzymes A and B in Humans: Detection of Native Species During CTL Responses In Vitro and In Vivo J. Immunol., April 1, 1998; 160(7): 3610 - 3616. [Abstract] [Full Text] [PDF]

				P. M. Jansen, B. Eisele, I. W. de Jong, A. Chang, U. Delvos, F. B. Taylor Jr., and C. E. Hack Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock J. Immunol., January 1, 1998; 160(1): 475 - 484. [Abstract] [Full Text] [PDF]

				P. Bruins, H. t. Velthuis, A. P. Yazdanbakhsh, P. G. M. Jansen, F. W. J. van Hardevelt, E. M. F. H. de Beaumont, C. R. H. Wildevuur, L. Eijsman, A. Trouwborst, and C. E. Hack Activation of the Complement System During and After Cardiopulmonary Bypass Surgery : Postsurgery Activation Involves C-Reactive Protein and Is Associated With Postoperative Arrhythmia Circulation, November 18, 1997; 96(10): 3542 - 3548. [Abstract] [Full Text]

				W. K. Lagrand, H. W.M. Niessen, G.-J. Wolbink, L. H. Jaspars, C. A. Visser, F. W.A. Verheugt, C. J.L.M. Meijer, and C. E. Hack C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction Circulation, January 7, 1997; 95(1): 97 - 103. [Abstract] [Full Text]

				H. t. Velthuis, P. G. M. Jansen, C. E. Hack, L. Eijsman, and C. R. H. Wildevuur Specific Complement Inhibition With Heparin-Coated Extracorporeal Circuits Ann. Thorac. Surg., April 1, 1996; 61(4): 1153 - 1157. [Abstract] [Full Text]